Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Kim, Hang-Raia; b; 1 | Park, Young Hoa; b; 1 | Jang, Jae-Wonc | Park, So Younga; b | Wang, Min Jeonga; b | Baek, Min Jaea | Kim, Beom Joona; b | Ahn, Soyeond | Kim, SangYuna; b; *
Affiliations: [a] Clinical Neuroscience Center, Seoul National University Bundang Hospital, Seongnam, Republic of Korea | [b] Department of Neurology, Seoul National University College of Medicine, Seoul, Republic of Korea | [c] Department of Neurology, Kangwon National University Hospital, Chuncheon, Republic of Korea | [d] Medical Research Collaborating Center, Seoul National University Bundang Hospital, Seongnam, Republic of Korea
Correspondence: [*] Correspondence to: SangYun Kim, MD, PhD, Clinical Neuroscience Center, Seoul National University Bundang Hospital, 82, Gumi-ro 173 Beon-gil, Bundang-gu, Seongnam-si, Gyeonggi-do 463-707, Korea. Tel.: +82 31 787 7462; Fax: +82 31 787 4059; E-mail: [email protected].
Note: [1] These authors contributed equally to this work.
Abstract: Background: Although medial temporal atrophy (MTA) is a useful imaging marker of the progression to dementia in mild cognitive impairment (MCI), substantial numbers of MCI patients without MTA still progress to dementia. Objective: We investigated whether visual ratings of posterior atrophy (PA) on magnetic resonance imaging show independent predictive value for the progression to dementia in MCI patients. Methods: This was a retrospective cohort study of elderly patients who visited Seoul National University Bundang Hospital between 2004 and 2012. A total of 148 patients who were initially diagnosed with MCI were followed for up to 3 years (median 22 months) to determine whether they progressed to dementia. We used 4-point and 5-point visual rating scales to assess PA and MTA, respectively. PA and MTA scores were dichotomized into normal (no atrophy) or abnormal (atrophy) in each patient. We performed a Cox regression analysis to examine the hazard ratios (HRs) of PA and MTA for the progression to dementia with adjustment for age, APOE ɛ4 allele status, and baseline Mini-Mental State Examination score. Results: Among the study population, 47 patients progressed to dementia. Visual assessment of the MRI scans revealed that 67 patients (45.3%) showed PA, whereas 85 patients (57.3%) showed MTA. The HRs with 95% confidence intervals for PA and MTA were 2.516 (1.244–5.091) and 4.238 (1.680–10.687), respectively. The predictive values of visually assessed PA and MTA remained significant, independent of the covariates. Conclusion: Visual assessment of PA has independent predictive value for progression to dementia in MCI patients.
Keywords: Atrophy, biomarker, disease progression, mild cognitive impairment
DOI: 10.3233/JAD-160339
Journal: Journal of Alzheimer's Disease, vol. 55, no. 1, pp. 137-146, 2017
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]